Project: Research
Status | Finished |
---|---|
Effective start/end date | 1/09/15 → 31/08/16 |
ViiV Healthcare/GlaxoSmithKline: £221,997, ViiV Healthcare/GlaxoSmithKline: £89,787
Research output: Contribution to journal › Meeting abstract
Research output: Other contribution
Research output: Contribution to journal › Meeting abstract
Research output: Contribution to journal › Conference article
Research output: Contribution to conference › Poster
Research output: Contribution to conference › Poster
Research output: Contribution to conference › Poster
Research output: Contribution to journal › Meeting abstract
Research output: Contribution to journal › Meeting abstract
Research output: Contribution to journal › Meeting abstract
ID: 24160609